Luigi Formisano
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 191 publications
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.
Journal: Expert review of anticancer therapy
Published: June 30, 2026
Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.
Journal: Melanoma research
Published: May 11, 2026
Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study).
Journal: Minerva urology and nephrology
Published: April 23, 2026
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.
Journal: Current oncology (Toronto, Ont.)
Published: April 22, 2026
Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: April 08, 2026
DNA hydroxymethylation of NCX1 heart promoter by GATA6/TET3 epigenetic complex participates in neuroprotection induced by hypoxic preconditioning.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 11, 2026
The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study.
Journal: The oncologist
Published: February 08, 2026
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.
Journal: Therapeutic advances in medical oncology
Published: January 26, 2026
Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a multicenter analysis from the Campania Oncological Network (ROC).
Journal: BMC cancer
Published: January 20, 2026
Salvage radiotherapy with or without hormonal therapy for biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis.
Journal: Prostate cancer and prostatic diseases
Published: December 23, 2025
Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models.
Journal: Breast cancer research : BCR
Published: December 22, 2025
SYNERGY in uro-oncology: multidisciplinary strategies for organ preservation beyond BCG failure.
Journal: Minerva urology and nephrology
Published: December 18, 2025
Last Updated: 09/26/2026